Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F91YE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $101,150
Award facts
- Contract value 100% obligated
- $101,150.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $101,150.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 22, 2026, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with an ultimate completion date of January 23, 2026. This non-competitive delivery order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract value: $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs for military and veteran healthcare systems. The company maintains extensive experience fulfilling DLA contracts across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. Zepbound, a GLP-1 receptor agonist indicated for weight management, represents the company's continued role in supplying pharmaceutical products to support military health operations. The award carries no set-aside designation and reflects AmerisourceBergen's competitive capability to meet federal procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F91YE?
SPE2DR26F91YE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F91YE worth?
The government has obligated $101,150 on SPE2DR26F91YE.
Is contract SPE2DR26F91YE an order under another contract?
Yes. SPE2DR26F91YE is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F91YE competed?
The extent of competition for SPE2DR26F91YE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award